USC.edu
Are You a Patient?

Cecily Jenkins, PhD

Associate Professor of Clinical Neurology

Image of Cecily Jenkins, PhD
Is this your profile? Click to edit
Phone +1 858 964 1453
Email cecily.jenkins@usc.edu
CTSI Profile

Overview

Cecily Jenkins, PhD is Associate Professor of Clinical Neurology in USC’s Alzheimer’s Therapeutic Research Institute (ATRI). As a licensed clinical neuropsychologist with expertise in cognitive assessment of older adults, her professional trajectory found focus in neurodegenerative conditions of aging for the past three decades. In the University of California, San Diego Department of Neurosciences Dr. Jenkins established and directed the Memory in Aging Project (MAP) and Memory Screening initiatives within the Shiley-Marcos Alzheimer’s Disease Research Center. There she led efforts to strengthen academic-public research partnerships in the San Diego community through outreach programs offering public education about memory research, brief cognitive assessment for older adults concerned about memory decline, and through facilitation of support programs for patients with Alzheimer’s Disease and their care-partners.

In her current position as Director of Neuropsychology at ATRI Dr. Jenkins plays a key role in the conduct of ATRI and the NIH funded Alzheimer’s Clinical Trials Consortium (ACTC). She manages the ACTC Clinical Outcome Instruments Unit, a team of internationally recognized experts advising ATRI and ACTC affiliated trialists and their academic/industry partners in selection of cognitive and clinical scales appropriate to the research questions. The team also provides operational guidance to promote clean data capture. Dr. Jenkins’ Neuropsychology team enforces rigorous training and certification standards for trial site personnel conducting cognitive assessments when these are primary study outcomes. She also directs expert quality review of collected data in select trials of disease-modifying interventions for pre-clinical Alzheimer’s Disease.

Publications

  • Safety, Efficacy, and Feasibility of Intranasal Insulin for the Treatment of Mild Cognitive Impairment and Alzheimer Disease Dementia: A Randomized Clinical Trial JAMA Neurol. 2020 09 01; 77(9):1099-1109. . View in PubMed
  • Community memory screening as a strategy for recruiting older adults into Alzheimer’s disease research Alzheimers Res Ther. 2020 06 30; 12(1):78. . View in PubMed
  • Detection of Rater Errors on Cognitive Instruments in a Clinical Trial Setting J Prev Alzheimers Dis. 2018; 5(3):188-196. . View in PubMed
  • Temporal sequence learning in healthy aging and amnestic mild cognitive impairment Exp Aging Res. 2013; 39(4):371-81. . View in PubMed
  • When help becomes a hindrance: mental health referral systems as barriers to care for primary care physicians treating patients with Alzheimer’s disease Am J Geriatr Psychiatry. 2010 Jul; 18(7):576-85. . View in PubMed
  • Longitudinal MRI findings from the vitamin E and donepezil treatment study for MCI Neurobiol Aging. 2008 Sep; 29(9):1285-95. . View in PubMed
  • Deterioration of visual-perceptual organization ability in Alzheimer’s disease Cortex. 2007 Oct; 43(7):967-75. . View in PubMed
  • Effectiveness of support groups for people with mild to moderate Alzheimer’s disease: an evaluative survey Am J Alzheimers Dis Other Demen. 2007 Feb-Mar; 22(1):14-9. . View in PubMed
  • Identification of Alzheimer disease risk by functional magnetic resonance imaging Arch Neurol. 2005 Dec; 62(12):1881-8. . View in PubMed
  • Incidence of and risk factors for hallucinations and delusions in patients with probable AD Neurology. 2000 May 23; 54(10):1965-71. . View in PubMed
  • The neuropsychology of aging Current Opinion in Psychiatry. 1994; 7:347-353. . View in PubMed
  • Structural organization of discourse production
    following right hemisphere damage Journal of Clinical and Experimental Neuropsychology. 1992; 14(1):40. . View in PubMed
  • Freebase cocaine and memory Comprehensive Psychiatry. 1990; 31(4):369-375. . View in PubMed
  • Characteristics of freebase cocaine psychosis The Yale Journal of Biology and Medicine. 1988; 61:115-122. . View in PubMed
  • Semantic priming in thought disordered schizophrenic patients Schizophrenic Research. 1988; 1:61-66. . View in PubMed
  • Cloze analysis in schizophrenic speech: Scoring method and rater’s education Perceptual and Motor Skills. 1988; 67:911-918. . View in PubMed
  • Positive and Negative Symptoms of PsychosisIn P. Harvey and E. Walker
    (Eds. ), Lawrence Erlbaum Associates:
    Hillsdale, New Jersey.
    . Thought disorder and measured features of language production in schizophrenia. 1987. . View in PubMed

Similar People